A smart brain biopsy needle for faster and safer neurosurgery has received $1 million from the Australian Government’s BioMedTech Horizons program, operated by MTPConnect.
When the Reserve Bank of Australia wanted to develop new security technologies for bank notes, Prof Jim Piper’s Advanced Imaging research group in the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) at Macquarie University had an answer: timecoded nanoparticles. Continue reading
Originally published by UNSW:
Non-invasive colour analysis of cells could one day be used in diagnostics, a proof-of-concept study has shown. Continue reading
CNBP AI at Macquarie University and Early Career Fellow at the Cancer Institute NSW, Dr Andrew Care, has presented his research to a packed house at a ‘Pint of Science’ public outreach and engagement event, 20th May 2019.
Held at the Nags Head Hotel, Glebe, Sydney, Dr Care talked about the latest in cancer research with a particular focus on a newly discovered class of biologically-derived nanoparticles (protein nanocages), and how they can be genetically-engineered to target and destroy tumours.
“Taking my science out to the public was great fun,” he says. “But more importantly it was a good opportunity to highlight that positive advances we are making in the fight against disease thanks to ongoing research investment in Australia,” he said.
Dr Care added, “I checked out Pint of Science for the first time last year. I saw a great talk by Dr Orazio Vittorio a cancer biologist from Children’s Cancer Institute Australia. After a chat at the pub about our research, we started a collaboration. A year later Orazio and I are developing an exciting new tool for cancer treatment! Together, we’ve also obtained research funding, and we’re about to file a patent and to publish our first paper together. None of this would have possible without Pint!”
“Talking at Pint of Science this year is my way of giving back and saying thanks for making a great collaboration happen…and maybe to find another awesome collaborator lurking in the pub again,” he concludes.
Dr Care’s research group combines techniques from synthetic biology and nanomedicine for the targeted treatment of cancer. More information on his exciting work can be found in his profile here.
A new automated non-invasive technique for diagnosing eye surface cancer (ocular surface squamous neoplasia or OSSN) has been developed by CNBP researchers and collaborators. The technique has the potential to reduce the need for biopsies, prevent therapy delays and make treatment far more effective for patients.
Read more in a news item on the Australian Medical Association website.
Scientists from the CNBP have reported an advanced imaging technique that allows the condition of joint cartilage to be examined—right down to the molecular level. The technique has potential for diagnostics and treatment-planning of cartilage disease and impairment, including for osteoarthritis.
Read more from the news item posted on the Medical Xpress web site.
CNBP researchers have developed a new form of nanoparticle and associated imaging technique that can detect multiple disease biomarkers, including those for breast cancer, found in deep-tissue in the body.
Read more about this exciting research in the news article published in the online publication Health Canal.
Innovative drug filled nano-bubbles, able to be successfully triggered in the body by X-rays, have been developed by CNBP researchers, paving the way for a new range of cancer treatments for patients.
Read more about this innovative science in the news article featured online in R&D Magazine.
A new technique, ‘bleaching-assisted multichannel microscopy’ (BAMM) takes a current long-standing weakness of fluorescence microscopy – photobleaching – and turns it into a strength that improves imaging output by up to three times, with no additional hardware required. Read more about this exciting development from CNBP researchers at the online channel PHYS ORG.
Australian neuroscientist and CNBP Director, Professor Mark Hutchinson who is developing a world-first blood test that identifies chronic pain by colour “biomarkers” is featured by NZ Doctor online. Prof Hutchinson believes that the breakthrough work has the potential to revolutionise the diagnosis and treatment for the one in five people in Australia and New Zealand who suffer from chronic pain.